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In many bacteria, a homodimer of structural-
maintenance-of-chromosomes proteins associates
with two regulatory subunits (known as ScpA and
ScpB), assembling a protein complex that plays
a crucial role in chromosome organization and segre-
gation. It remains poorly understood, however, how
this complex might work at the mechanistic level.
Here, we report crystal structures of the ScpAB
core complex that display a highly unusual structure
in which the central segment of ScpA winds around
an asymmetrically oriented ScpB dimer. The two
C-terminal domains of the ScpB dimer primarily
interact with different regions of ScpA with different
affinities. Moreover, flexible interdomain regions of
ScpB contribute to a dynamic folding process of
the ScpAB subcomplex. Together with other genetic
and biochemical assays, we provide evidence that
internal structural changes of the ScpAB subcom-
plex are tightly coupled with activation of the struc-
tural-maintenance-of-chromosomes ATPase.
INTRODUCTION
Structural-maintenance-of-chromosomes (SMC) protein com-
plexes are some of themost fundamental molecular machineries
that regulate large-scale chromosome organization and func-
tions from bacteria to humans (Losada and Hirano, 2005; Nas-
myth and Haering, 2005). In eukaryotes, heteromeric SMC
dimers constitute the core of the cohesin and condensin com-
plexes that play central roles in sister-chromatid cohesion and
chromosome condensation, respectively (Hirano, 2012; Onn
et al., 2008; Peters et al., 2008). In bacteria, a homomeric SMC
dimer functions as the core of a condensin-like complex (Grau-
mann and Knust, 2009). Both heteromeric and homomeric
SMC dimers display a highly characteristic V-shaped architec-
ture that has two ATP-binding-cassette-type ‘‘head’’ domains
at its distal ends (Anderson et al., 2002; Melby et al., 1998). ATP
binding and hydrolysis control engagement and disengagement
of the SMC head domains, and it is believed that such a catalytic
cycle regulates dynamic interaction of the SMC dimer with DNA.Structure 21In the Gram-positive bacterium Bacillus subtilis, the SMC
protein, together with its regulatory subunits, ScpA and ScpB,
participates in global organization and segregation of chromo-
somes (Britton et al., 1998; Jensen and Shapiro, 1999; Mascare-
nhas et al., 2002; Moriya et al., 1998; Soppa et al., 2002). Like
SMC, ScpA and ScpB are widely conserved among prokaryotes
(Mascarenhas et al., 2002; Volkov et al., 2003). Null mutations in
these three genes cause a similar set of defective phenotypes:
chromosome organization and segregation are grossly compro-
mised, leading to the formation of anucleate cells at high
frequencies. ScpA and ScpB are colocalized with SMC to form
discrete foci, and these three proteins are positioned interde-
pendently in vivo (Lindow et al., 2002; Volkov et al., 2003). In
fact, ScpA interacts with the SMC head domain and ScpB, sup-
porting the assembly of a ternary complex in vitro, while ScpB
does not apparently bind to SMC. The exact subunit stoichiom-
etry of the two factors in the complex remains controversial
(Fuentes-Perez et al., 2012; Hirano and Hirano, 2004; Mascare-
nhas et al., 2005). Crystal structures of ScpB from Chlorobium
tepidum and Mycobacterium tuberculosis demonstrate that
ScpB forms a stable dimer through its N-terminal winged-helix
domain (Kim et al., 2006, 2008). No structural information is
currently available for ScpA or the ScpAB complex, and the
mechanism of activation of SMC ATPase by ScpA and ScpB,
is not fully understood.
In a subfamily of g-proteobacteria including Escherichia coli,
a distinct complex known as MukBEF is believed to function
as a structural and functional homolog of SMC-ScpAB (Yama-
zoe et al., 1999), although the corresponding subunits (i.e.,
MukB/SMC, MukE/ScpB, and MukF/ScpA) share very little
similarity to each other at the primary structure level. For
instance, MukF is much larger than ScpA and has the ability to
form a stable dimeric core (Fennell-Fezzie et al., 2005). MukB
compacts single DNA molecules in a highly cooperative manner
in vitro (Cui et al., 2008). The MukEF subcomplex stimulates
MukB’s ATPase activity (Woo et al., 2009) but restricts DNA
reshaping mediated by MukB (Petrushenko et al., 2006).
Biochemical and crystallographic studies have revealed that
ATP-dependent engagement of MukB head domains disrupts
a MukB-MukF interaction (Woo et al., 2009). It was proposed
that the ATP-hydrolysis energy is utilized for subunit rearrange-
ment, leading to the oligomerization of MukB through a rigid
structural bridge composed of the MukEF subcomplex. It
remains unknown whether a similar mechanismmight also oper-
ate in the action of SMC-ScpAB., 581–594, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 581
Table 1. Data Collection and Refinement Statistics for ScpAB
Complexes
ScpAB Core
Native
ScpAB Core
MeHgCl
Derivative
ScpB
NTD-ScpA
Peptide
Data Collection
Space group P21 P21 C2
Cell Dimensions
a, b, c (A˚) 90.86, 127.42,
97.22
90.91, 127.59,
97.10
107.82, 88.92,
60.68
a, b, g () 90, 113.84, 90 90, 113.69, 90 90, 94.31, 90
Peak
Wavelength 1.00000 1.00556 1.00000
Resolution (A˚) 50.0–2.6 50.0–2.65 50.0–2.4
Rsym
a 6.3 (66.9) 5.6 (40.8) 5.1 (11.6)
I/sI 19.8 (1.6) 18.6 (1.5) 17.2 (8.4)
Completeness (%) 98.5 (89.5) 97.1 (79.6) 99.4 (89.8)
Redundancy 3.9 (3.6) 1.9 (1.7) 3.8 (3.6)
Figure of Meritb
Acentric/Centric 0.297/0.143
Total 0.274
Refinement
Resolution (A˚) 30.7-2.6 46-2.4
No. of reflections 61,951 23,058
Rwork/Rfree
c 0.225/0.266 0.236/0.285
No. of Atoms
Protein 7,505 2,860
Solvent 43 101
B-Factors (A˚2)
Protein 67.60 35.38
Solvent 40.36 35.42
Rmsdd
Bond lengths (A˚) 0.009 0.009
Bond angles () 1.181 1.296
Values in parentheses are for the highest-resolution shell.
aRsym = SjI  hIi j/SI, where I is the observed intensity and hIi is the
average intensity obtained from multiple observations of symmetry-
related reflections.
bFigure of merit =
P
P(a)eia/
P
P(a), where a is the phase and P(a) is the
phase probability distribution.
cFree R factor was calculated with 5% of randomly selected data omitted
from the structure refinement.
dRoot-mean-square deviation (Rmsd) bond lengths and Rmsd bond
angles are the respective Rmsds from ideal values.
Structure
Crystal Structure of ScpAB ComplexIn the current study, we report the crystal structure of a
functional subcomplex of the Geobacillus stearothermophilus
ScpAB. The ScpAB core complex displays an unprecedented
structure in which a central segment of ScpA winds around an
asymmetrically oriented ScpB dimer. A combination of biochem-
ical and genetic data provide evidence that this structure repre-
sents a latent form of ScpAB, which conceals the central
segment of ScpA required for stimulation of the SMC ATPase
activity. Our results strongly suggest that dynamic internal struc-
tural changes of the ScpAB subcomplex actively regulate SMC
ATPase activity, and they offer broad implications for our under-
standing of the action of bacterial and eukaryotic SMC protein
complexes.
RESULTS AND DISCUSSION
Structure Determination of the ScpAB Core Complex
Two SMC regulatory subunits, ScpA and ScpB, from
G. stearothermophilus were coexpressed and purified as a
complex. As judged by gel filtration and SDS-PAGE, the re-
combinant behaves as a single protein complex, with an
apparent stoichiometry of 2:4. Limited proteolysis and mass
spectrometry analyses demonstrated that ScpA in the complex
form has a domain boundary that separates its C-terminal
domain from the rest of the part (Figure S1A available online).
On the basis of the information obtained, we redesigned expres-
sion constructs, and found that ScpA lacks its C-terminal region
(1–174) and that ScpB trimmed from both flexible ends (12–191)
formed an 61 kDa complex with 1:2 stoichiometry in good
homogeneity (Figures S2A and S2B). We interpreted these
results as follows. The C-terminal domain of ScpA would bind
to the SMC head domain when it was available, as had been
demonstrated for other kleisin subunits (Haering et al., 2004;
Woo et al., 2009), and as will be shown later in this study. In
the initially purified fraction of full-length ScpAB, the ScpA
C-terminal domains weakly associated with each other to form
an apparent dimer unit, because its exposed hydrophobic
surface needed to be hidden under the aqueous solutions where
the intrinsic binding partner (i.e., the SMC head domain) was
absent. In the current study, the second, truncated version of
the complex (henceforth referred to as the ScpAB core) was
crystallized, and its structure was determined by the single-
anomalous-dispersion method, and was refined to a resolution
of 2.6 A˚ (Table 1).
ScpA Winds around an Asymmetrically Oriented ScpB
Dimer
The ScpAB core structure is composed of four winged-helix
domains (wHDs) from the ScpB homodimer with a single poly-
peptide of ScpA (Figures 1A and 1B). Electrostatic calculations
of the complex showed that the molecular surface is largely
acidic (Figures S3A–S3C). Each ScpB protomer consists of
two tandem-aligned wHDs that are connected by an interdomain
(ID) region (Figure 1B). The N-terminal wHD (NTD) is responsible
for dimerization of ScpB within the core complex, as has been
described previously in the structures of ScpB homodimer free
of ScpA (Kim et al., 2006, 2008). Intriguingly, however, unlike in
the ScpA-free ScpB homodimer, the two C-terminal wHDs
(CTDs) of ScpB are asymmetrically oriented within the core582 Structure 21, 581–594, April 2, 2013 ª2013 Elsevier Ltd All rightscomplex (Figure S3D). In our ScpAB core structure, the CTD of
the anterior ScpB (ScpBan) binds to helix H5 of ScpA, whereas
the CTD of the posterior ScpB (ScpBpo) binds to helix H7 of
ScpA. Moreover, the central segment of ScpA is located under-
neath the NTD dimer and winds around the ID region of ScpBpo
(Figure 1A). This unexpected folding of the ScpAB core complex
is achieved by a series of local interactions between residues of
ScpA andScpB, which in turn stabilize the overall structure of the
heterotrimeric complex. In addition, the two ID regions in the
ScpB homodimer adopt different conformations to maintainreserved
Figure 1. Structure of the ScpAB Core Complex
(A) Overall structure of the ScpAB core complex with schematic drawings. Shown at left is a ribbon drawing and its schematic representation of the ScpA
monomer bound to the ScpB homodimer viewed perpendicular to the 2-fold axis of the symmetrical ScpB N-terminal dimer. The N- and C-termini of the subunits
and principal secondary-structure elements are labeled. Shown at right is the junction region of the ScpA winding segment viewed from the top with surface
representation of ScpB, except that the N-terminal dimer is transparent.
(B) Domain architecture of ScpA and ScpB. ScpA is comprised of the N-terminal helix-bundled domain (NTD), a central winding segment, and the C-terminal
winged-helix domain (CTD). The ScpA CTD is shown here as a blank bar, because it is not included in the crystal structure. ScpB is composed of the N-terminal
winged-helix domain (magenta and slate), an interdomain (ID) region (yellow) and the winged-helix C-terminal domain (light pink and cyan).
(C) Details of the ScpBan ID region. The extended peptide forms a short antiparallel b sheet with the peptide following from the ScpA helix H7.
(D) Details of the ScpBpo ID region. A structural constraint imposed by the winding segment makes the ID region fold compactly by partial helix extensions from
both H4 and H10 helices.
See also Figures S1–S4 and Table S1.
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Structure
Crystal Structure of ScpAB Complexthe characteristic form of the complex (Figures 1C and 1D). Thus,
the ScpB dimer contributes to the folding of ScpA in a highly intri-
cate manner, so that the resulting trimeric subcomplex forms
a compact architecture.
Although it had previously been predicted that the ScpA NTD
is folded into a winged helix (Fennell-Fezzie et al., 2005), we
noticed that the domain in our structure contains only four short
helices. Alignment by the Dail server (Holm and Rosenstro¨m,
2010) demonstrated that spatial orientation of the secondary
structural elements within the ScpA NTD is dissimilar to that of
a typical wHD, and that the ScpA NTD rather resembles a four-
helix-bundle domain. In fact, E. coli MukF has a four-helix-
bundle domain in the corresponding position, apart from its
N-terminal wHD that is responsible for dimerization (Figures
S4A and S4B). These considerations, together with the homog-
enous properties of the ScpAB core complex, suggest that the
ScpA NTD is unlikely to be responsible for its own dimerization.
Helix H5, which stems from the ScpA NTD, primarily contributes
to its interaction with the ScpBan CTD (Figure 1A). The following
short segments of ScpA, strand S1 and helix H6, contact under-
neath the dimeric ScpB NTD, and are curved down along the
edge of the ID region of ScpBpo. After a short missing region
with low electron density, the next helix of ScpA, H7, is sand-
wiched between the two ScpB CTDs (Figure 1D), and the subse-
quent strand, S2, is located under and across the peptide. In this
junction point, the downstream region of ScpA does not make
significant contact with strand S1 but forms a short antiparallel
b sheet with the ID region of ScpBan (Figure 1C).
Dual Recognition Scheme of the ScpB CTD for ScpA
Binding
Binding areas between ScpA and ScpB dimers are extensive
(the total buried surface area is 3,900 A˚2), and more than half
of the residues in the ScpA winding segment participate in its
intermolecular contacts with ScpB (Figure S1A). In particular,
binding of ScpA helices H5 and H7 to the ScpB CTDs occupies
about half of the areas (1,170 A˚2 and 750 A˚2, respectively).
ScpA helix H5 is laid almost perpendicular to ScpBan helix H1’
(Figure 2A), and a similar orientation is preserved between
ScpA helix H7 and ScpBpo helix H1’ (Figure 2B). Moreover, bulky
hydrophobic residues of ScpA, Leu119 in helix H5 andMet156 in
helix H7, recognize the deepest dents of the ScpBan and ScpBpo
CTDs, respectively. It is very interesting to note, however, that
the H5 and H7 helices of ScpA are oppositely oriented relative
to the ScpB CTDs, so that surface residues of the two CTDs
are organized to form suitable contacts for each ScpA helix.
For example, the bulky residue Phe112 in ScpA helix H5 makes
a close contact with Leu179 of ScpBan (Figure 2A). On the other
hand, Leu160 and Leu164, located on the same surface of the
ScpA H7 helix, are distant from Leu179 of ScpBpo and instead
make contact with Trp182 (Figure 2B), which is invisible in
ScpBan. In another case, Leu100 of ScpBan is engaged to form
a hydrophobic surface with its neighboring residue, Leu105, to
make a contact with the aliphatic portion of Lys120 of ScpA helix
H5 (Figure 2A). In the ScpBpo CTD, however, the corresponding
Leu100 is flipped back in the opposite direction, and Leu149 and
Val151 of ScpA compensate by filling the hollowed surface of the
ScpBpo CTD and stabilizing the L-shaped form of ScpA (Fig-
ure 2B). The conformational change of Leu100 is assisted by584 Structure 21, 581–594, April 2, 2013 ª2013 Elsevier Ltd All rightsmotion of the neighboring conserved residue Ser101, which
alters its hydrogen-bond partners of main-chain atoms (Figures
S3E and S3F). Interestingly, the two types of peptide trajectories
to the ScpB CTD have been observed in two different crystal
structures of ScpA-free ScpB homodimer (Figure S3E). Thus, it
is most likely that Ser101 acts as a key determinant in facilitating
the dual binding modes of the ScpB CTD. The C-terminal exten-
sion of the ScpB CTDs can be traced clearly in the ScpAB core
structure (Figure 1A), although they were not visible in the ScpA-
free ScpB structures reported previously (Figure S3E). This
disorder-to-order transition seems to be essential for formation
of the complex.
To further assess the differential contributions of the two ScpB
CTDs to their binding to ScpA, we applied isothermal titration
calorimetry (ITC). The dissociation constant (Kd) for ScpB(12–
191)/ScpA(1–174), the pair of materials used for crystallization,
was estimated to be 56 nM (Figure 2C), and the stoichiometry
of ScpB/ScpA was close to 2. Interestingly, whereas the ScpB
CTD(98–217) bound to ScpA(1–143) with a 1:1 stoichiometry,
the Kd for them was close to the value found with the ScpAB
complex (51 nM; Figure 2D). In striking contrast, the binding
of ScpB CTD to a synthetic peptide, ScpA(147–166), was
much weaker than those mentioned above (Kd = 2.2 mM) (Fig-
ure 2E). Another titration analysis using the ScpB CTD and
ScpA(1–174) presented a reasonable simultaneous fitting for
the two sites (Kd = 32 nM and 0.29 mM) (Figure 2F). These
results suggest that the tight binding of the ScpBan CTD to
ScpA helix H5 (and the ScpA NTD) makes a primary contribution
to the stoichiometric formation of the complex. The contribution
of the weaker binding of ScpBpo to ScpA helix H7 is secondary,
implying that there exists a structural hierarchy in the folding
process to make the unusual architecture of the ScpAB core
complex.
A Variable ScpB ID Region Guides the Assembly of the
ScpAB Complex
Part of the winding segment of ScpA (from strand S1 to helix H6)
is housed by the symmetrical ScpBNTD dimer. Nonetheless, our
ITC experiments failed to detect binding of the ScpB NTD (12–
99) dimer to a synthetic ScpA peptide (125–142), suggesting
that interaction between the two is rather weak. Then how might
the dimerized ScpB NTDs contribute to holding the ScpA
winding segment? To address this question, we attempted
another crystallographic approach and obtained crystals of
ScpB NTD (12–99) dimer with a synthetic ScpA peptide (125–
142). The structure was solved by molecular replacement using
the NTD dimer from the ScpAB core complex as a searchmodel.
The model was refined to a resolution of 2.4 A˚ with good stereo-
chemistry (Table 1).
The structure of the ScpB NTD dimer in this crystal was essen-
tially identical to that seen in theScpABcore complex (Figure 3A).
The synthetic ScpA peptide is also accommodated, with a fixed
orientation, in a trench on the underside of the symmetric NTD
dimer. We noticed, however, that the ID region of ScpBan in
this structure displays a different conformation, forming a short
stretch of an antiparallel b sheet with the N-terminal half of
the ScpA peptide (Figure 3A). Pro95 in the ID region contributes
to making local hydrophobic contacts with the bulky Phe130
residue of the ScpA peptide on the ScpBan NTD surface.reserved
Figure 2. Molecular Properties of Two ScpB CTDs for ScpA Binding
(A and B) Close-up views of two amphipathic helices of ScpA, H5 (A) and H7 (B), bound to the hydrophobic concave surface of the ScpB CTD. Hydrophobic
residues involved in these interfaces are shown along with the molecular surface of ScpB CTDs. Two key residues (Leu100 and Ser101) in the ScpBpo ID region
are also shown (see also Figure S3F).
(C–F) Isothermal titration calorimetry data for interactions between various constructs of ScpA and ScpB. The calorimetric titrations of 0.66 mM of ScpB(12–191)
into 0.040mMof ScpA(1–174) with 1.83 107 ± 2.13 106M1 ofKb (C), 0.73mMof ScpB(98–217) into 0.050mMof ScpA(1–143) with 2.03 10
7 ± 2.43 106M1 of
Kb (D), 0.73 mM of ScpB(98–217) into 0.050 mM of ScpA(147–166) with 4.6 3 10
5 ± 2.1 3 104 M1of Kb (E), and 0.73 mM of ScpB(98–217) into 0.040 mM of
ScpA(1–174) with 3.53 106 ± 3.33 105 M1and 3.13 107 ± 8.13 106 M1of Kb for two sites (F). The curves in the ITC panels are fit to a one-set-of-sites model,
except for (F), which is fit to two sets of sites.
See also Figure S3 and Table S1.
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Figure 3. Structure of ScpB NTD Dimer with an ScpA Peptide and Folding Steps of the ScpAB Core Complex
(A) Detailed view of the ScpBNTD dimer (gray) complexed with the ScpA peptide (125–142; light green). The ScpBan ID region (from Ala94 to Pro99; orange) alters
its conformation and captures the ScpA peptide.
(B) Exploded view of the junction point of ScpA with two complex structures superimposed using NTD dimer structures. The ScpBan ID region seen in the NTD
dimer complex (orange) is spatially incompatible with a subsequent region from the end of helix H7 of the ScpAB complex.
(C) Schematic diagram of the predicted folding scheme of ScpAB. Binding of the ScpBan CTD to the ScpA NTD directs binding of the ScpBpo CTD to ScpA
helix H7. Helix H5 of ScpA would extend substantially when it interacts with the ScpBan CTD, while helix H7 would be induced to form upon binding to the
ScpBpo CTD. The ID region of ScpBan guides ScpA interaction underneath the NTD dimer, and then is purged aside to finalize the formation of the closed form
of ScpAB.
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Figure 4. Dominant-Negative Effects of ScpA and ScpB Mutations
In Vivo
(A) The viability of the BCKA4-based strains expressing functional domains of
BsScpB. Serial (10-fold) dilutions of their cultures were spotted on agar plates
containing the indicated concentrations of IPTG or xylose.
(B) The viability of the BCKA3-based strains expressing BsScpA with various
3-Ala mutations in its helix H7. The sequence of the mutated region of BsScpA
is indicated at the bottom.
(C) The viability of the BCKA3-based strains expressing BsScpA with point
mutations around its helix H7 region.
See Figures S5, S6, and Table S2.
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Crystal Structure of ScpAB ComplexMoreover, the next residue, Gly96, modulates the conformation
of the rest of the ID region so that it runs alongside the ScpA
peptide. Although this interacting region of the ScpA peptide is
well ordered and follows the same trajectory observed in the
ScpAB core complex, the following helix, H6, is highly deviated
due to weak density (Figure 3B). The ID region of ScpBan recog-
nizes the ScpA peptide, following helix H5. In contrast, the ID
region of ScpBpo is totally disordered in this structure (Figure 3B).
It is suggested that the ScpBan ID region guides a smooth place-
ment of the ScpA peptide underneath the ScpB NTD dimer after
the ScpBan CTD recognizes ScpA helix H5.
Proposed Steps for ScpAB Subcomplex Formation
The current study provides structural insights into a series of
steps that support the assembly and folding of the ScpAB
complex.Whenmonomeric ScpA is expressed as a recombinant
polypeptide, it is highly sensitive to proteases, indicating that the
bulk of ScpA is disordered and undergoes a disorder-to-order
transition upon binding to ScpB. We suggest that binding of
ScpA helix H5 to the ScpBan CTD represents the initial step of
the whole assembly process, which is further reinforced by an
induced-fit binding of the C-terminal extension of ScpBan (Fig-
ure 3C, step 1). The dimerized ScpB NTDs not only provide
a platform for placing ScpA underneath them, but also ensure
that the second CTD (i.e., the ScpBpo CTD) is placed in close
proximity to helix H7 (Figure 3C, step 2). At this step, the two
ID regions in the ScpB dimer change their own conformations
and work as adjusters to help fine-tune the global architecture
of the ScpAB complex. The ID region of ScpBan plays a guiding
role so that the region following ScpA helix H5 is eventually
placed underneath the dimerized NTDs of ScpA (Figure 3A).
Once the ScpBpo CTD captures helix H7, it rotates around its
own ID region (Figure 3C, step 3). Finally, helix H7 makes an
additional contact with the ScpBap CTD and is sealed by the
C-terminal extension of ScpBpo. Notably, the electrostatic-
potential surface surrounding the ScpA junction point is strongly
negatively charged (Figure S3C), whereas the ScpA sequence
following the H7 helix contains positively charged residues, sug-
gesting that docking of the highly polarized surfaces could
provide a major driving force to wind up the bound unit of
ScpA H7-ScpBpo CTD. We also infer that rotation of the bound
unit induces partial helix formation in the ScpBpo ID region (Fig-
ure 1A), which helps complete the folding of the ScpAB core
complex. At the same time, the ID region of ScpBan finishes its
role in introducing the ScpA peptide underneath the ScpB NTD
dimer and is released upon completion of the folding process
(Figures 3B and 3C, step 3).
Genetic Dissection of the ScpAB Subcomplex
To understand the role of individual domains in the regulatory
subcomplex in vivo, we set up genetic analyses in B. subtilis. It
had been shown previously that disruption of either scpA or
scpB causes temperature-sensitive lethality in complex media,
as had been demonstrated for smc (Soppa et al., 2002). There-
fore, we first constructed strains in which an isopropyl-b-D-1-
thiogalactopyranoside (IPTG)-inducible promoter controls the
endogenous level of BsScpAB or BsScpB alone (Figures S5A
and S5B). Then, mutant versions of BsScpA or BsScpB were
exogenously expressed in these strains under the control ofStructure 21a xylose-responsive promoter and assessed for their viability
under the condition where expression of the endogenous genes
was reduced (IPTG + xylose).
When the endogenous level of BsScpB is reduced in the
parental strain, cell growth is greatly impaired (Figure 4A,
BCKA11). Expression of full-length BsScpB restored cell viability
under this condition (BCKA12). To our surprise, expression of the
BsScpB CTD also restored cell viability (BCKA14). Introduction
of a mutation into the BsScpA-binding surface of BsScpB
(A99R) abolished its ability to restore viability (BCKA83). More-
over, we found that expression of the BsScpB CTD alone was
able to rescue even an scpB null mutant at 37C (Figure S6).
On the other hand, expression of the BsScpB NTD displayed
a dominant-negative effect in both the presence and absence
of IPTG (BCKA13), implying that NTDs might sequester func-
tional BsScpA under these conditions. The most plausible inter-
pretation for this phenotype is that the exogenously expressed
NTD causes inactivation of endogenous BsScpB by heterodimer, 581–594, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 587
Figure 5. Effects of Intrasubcomplex Motion of ScpAB on SMC ATPase Activity
(A) Time course of ATP hydrolysis by full-length SMC (50 nM [blue]) in the absence (diamonds) and presence of ScpAB. ScpAB was added to SMC at 1-fold
(circles), 2-fold (triangles), or 5-fold (squares) molar ratios. Also shown is ATP hydrolysis by the transition-state mutant, SMCTR (red). The smooth curve of the
hydrolysis rate in the inset is the best fits to the data using the Michaelis-Menten equation. The estimated Vmax and Km values were 45 min
1 and 0.97,
respectively.
(B) Effects of adding individually purified regulatory subunits on SMC ATPase. ATPase activities of full-length SMC (50 nM), with ScpA (wild-type and M156R
mutant) (50 nM) in the absence or presence of ScpB (100 nM), andwith purified ScpAB complex (50 nM) weremeasured. The activities are plotted as percentages
of a reference activity of SMC plus ScpAB.
(C) Schematic representations showing two disulfide-bridging sites used in crosslinking experiments (left). Shown at right are electrophoretic mobility shifts of
double cysteine mutants. The twomutated ScpAB complexes (CL1 and CL2) were either untreated (unt), oxidized (oxi), or oxidized and then reduced (red) before
being subjected to nonreducing SDS-PAGE. The crosslinked products are indicated by CL1 and CL2 on the right.
(legend continued on next page)
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Crystal Structure of ScpAB Complexformation, which in turn reduces binding frequency of the
BsScpB CTD for two sites of BsScpA. Thus, these observations
substantiate the functional importance of the ScpB CTD in vivo.
We next asked whether the weak interaction between the
ScpA helix H7 and ScpBpo CTD might play a critical role in vivo.
To this end, we used another parental strain in which the endog-
enous levels of both BsScpA and BsScpB were equally reduced
(Figures S5A and S5B, BCKA3). Because the extent of reduction
wasmodest and balanced, comparedwith the BsScpB-deficient
strain (Figure 4A, BCKA12), cell viability was not severely
affected in the absence of IPTG (Figure 4B, BCKA31). We then
replaced three successive residues in or near helix H7 with
alanines and expressed these mutant versions of BsScpA in
the parental strain. Remarkably, it was found that expression
of some of the BsScpA mutants displayed a strong dominant-
negative effect (i.e., Figure 4B, BCKA60, 61, 62, 64, and 70).
Furthermore, a single amino acid substitution of arginine for
Met153 (corresponding to Met156 in GsScpA) was sufficient to
suppress cell growth (Figure 4C, BCKA57). These results under-
score the importance of hydrophobic residues in ScpA helix H7
that are involved in binding to the ScpBpo CTD. Finally, similar
observations were made when hydrophobic residues (Ile174,
Ile179, and Pro180), located between the H7 helix and the CTD
of ScpA, were replaced with alanine (Figure 4C, BCKA103–
105), implying that this flexible region, missing in our crystal
structure, also plays an important function.
Evidence that Dynamic Conformational Changes of
ScpAB Modulate SMC ATPase
To investigate the role of ScpAB in regulating SMC ATPase
activity, we expressed and purified full-length SMC and various
functional domains of ScpA and/or ScpB (Figure S7A). The wild-
type SMC possessed a basal activity of ATP hydrolysis (11
ATP/min/mol), whereas its transition-state mutant (E1118Q) dis-
played virtually no activity (Figure 5A). Addition of purified ScpAB
complex substantially increased the ATPase activity of SMC in
a dose-dependent manner, although addition of ScpA or ScpB
alone barely or onlymildly affected the SMCATPase activity (Fig-
ure 5B). We reasoned that ScpA on its own is present as a latent
form in terms of stimulating SMC ATPase activity, and that ScpB
has an ability to convert ScpA into an active form, probably by
changing its conformation.
To test this hypothesis, we sought to introduce artificial disul-
fide crosslinking to fix the conformation of ScpAB in the closed
form, as seen in our crystal structure. In the first pair, ScpA helix
H7 (Tyr157) was designed to be crosslinked with the outer
surface of ScpBan CTD (Lys144) (Figure 5C, CL1). In the second
pair, ScpA strand S2 (Lys168) was designed to be crosslinked
with the ScpBan ID region (A94) (Figure 5C, CL2). When the pairs
of the polypeptides were coexpressed, purified, and placed
under an oxidized condition, designed crosslinking was ob-
served in both cases with high efficiency. As expected from
stoichiometry of the complex, half the amount of ScpB was left
uncrosslinked in each case, confirming that no unintentional(D) ATPase activities by full-length SMC (50 nM) in the absence and presence of
(E) Effects of various point mutations in ScpA and ScpB on the SMC ATPase activ
A schematic representation of the positions and postulated effects of the point mu
the ScpAB mutants).
Structure 21crosslinking occurred under the current condition. We then
added the crosslinkedmolecules of ScpAB in the ATPase assay,
and found that the ability of CL1 and CL2 to stimulate SMC
ATPase was reduced when crosslinked (Figure 5D, oxi), but
was restored to the original level when the crosslinking was
reversed (Figure 5D, red).
We next performed a test to see what would happen if ScpA-
ScpB interactions were loosened, rather than stabilized, by intro-
ducing point mutations (or a short deletion) on either subunit.
Introduction of a mutation in the central segment of ScpA
(F130R) or deletion of ScpA helix H6 (DH6) would disturb the
internal ScpAB structure by steric hindrance, thereby preventing
the formation of the closed form. As expected, the ScpAB sub-
complexes containing these mutations displayed higher levels
of ATPase stimulatory activity than did the wild-type ScpAB (Fig-
ure 5E). Similarly, when the ScpB ID region, which plays an
important role in consolidating the closed form, was mutated
(L91R and V92R), the resulting subcomplexes had higher stimu-
latory activities. Mutant complexes of Y154A in ScpA and A139R
in ScpB, which are designed for local disruption of the interface
between two ScpBCTDs, displayed amodest ability to stimulate
the SMCATPase. These results further substantiate the idea that
our crystal structure of the ScpAB core complex represents
a latent form, and that dynamic transformation of the substruc-
ture is necessary to stimulate SMC ATPase. We also tested
substitution of Met156 of ScpA (Met153 in BsScpA) with arginine
to disrupt the interaction of ScpA helix H7 with the ScpBpo CTD,
and found that the mutant complex exhibited a lower stimulatory
activity (Figures 5B and 5E). The subunit stoichiometry of the
mutant complex was altered to 1:1 (Figure S7B), which could
be explained by aberrant bridging of two ScpA molecules by
one ScpB dimer.
Interactions between the SMC Head Domain and ScpAB
To further understand the action of ScpAB, we looked at its
physical and functional interactions with the SMC head domain
(HD). We coexpressed the three subunits and purified a complex
(HDTRAB) composed of the HD with the transition-state mutation
and ScpAB. In the presence of ATP, HDTRAB dimerized to form
a double-sized complex with a stoichiometry of 2:2:4 (Figure 6A,
top). However, the formation of this homodimeric species was
apparently slow, as a substantial fraction of HDTRAB remained
as a monomeric species. On the other hand, when HDTRAB
and HDTR were mixed together, they readily formed a hetero-
meric complex with a stoichiometry of 2:1:2 (Figure 6A, bottom).
Thus, HDTRAB-HDTRAB engagement is less stable than
HDTRAB-HDTR engagement, suggesting that the ScpABs on
HDTR sterically repel each other, thereby selecting ScpAB-free
HD as a preferential engagement partner.
We then performed the ATPase assay using the HD and found
that it has a much lower level of basal activity (2 ATP/min/mol)
compared with full-length SMC (Figure 6B). ATP hydrolysis by
HDAB was even lower than that by HD. Interestingly, however,
when full-length SMC was mixed with a 10-fold excess amountuntreated, oxidized, and reduced forms of CL1 and CL2 (50 nM).
ity. Details of mutations introduced into each subunit are described in Table S1.
tations is shown at right (see also Figure S7B for gel filtration profiles of some of
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Figure 6. Physical and Functional Interactions between the SMC Head Domain and ScpAB
(A) Molecular species generated by ATP-dependent dimerization of the SMC head domain. (Top) HDTR-ScpAB (red and orange curves) and wild-type HD (green
and light green curves) were subjected to separate gel filtration experiments in the presence of ATP, and their elution chromatograms are overlaid. (Bottom)
Elution chromatogram of a mixture of HDTR-ScpAB and HDTR (blue and light blue curves) is shown.
(B) ATPase activities of full-length SMC, SMC HD, and their combinations. Different combinations of HD (250 nM), HDAB (250 nM), SMC (25 nM), and ScpAB
(50 nM) were used for ATPase assays. Note that 10-fold excess amounts of HD (HD3 10) or HDAB (HDAB3 10) over SMCwere used in this set of experiments. In
some of themixtures, the ScpA helix H7 peptide (147–166) was added at a final concentration of 50 mM (indicated by Ap). The activities are plotted as percentages
of a reference activity of SMC plus HD 3 10.
(C) ATPase activities of HD in the presence of various lengths of ScpA. HD (250 nM) was mixed with the same concentrations of ScpA (183–251) (A183), ScpA
(161–251) (A161), or ScpA (144–251) (A144), and ATPase activities of the mixtures were measured. When ScpBwas added, a concentration of 500 nMwas used.
The activities are plotted as percentages of a reference activity of HD plus A144.
(D) ATPase activities of HD plus A144 in the presence of the wild-type or mutated forms of the ScpA helix H7 peptide (147–166) (Ap). HD and A144 (250 nM of
each) were mixed with the peptides at a final concentration of 1 mM or 10 mM. The amino acid sequences of the synthetic peptides used here are indicated to
the right of the graph. A partially overlapping peptide, Ap2, was used as a negative control. The activities are plotted as percentages of a reference activity of HD
plus A144.
See also Figure S7 and Table S1.
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Figure 7. Hydrodynamic Property and Elec-
tron Microscopic Analysis of the Full-length
SMC-ScpAB Complexes
(A) (Top) SMC-ScpAB (blue and red curves) and
SMC dimer (green and orange curves) were sub-
jected to separate gel filtration experiments, and
their elution chromatograms are overlaid. (Bottom)
The wild-type and mutant (Walker-A [WA] and
transition-state [TR]) SMC-ScpAB complexes
were subjected to SDS-PAGE and their subunit
stoichiometries were estimated using purified
SMC and ScpAB as standards.
(B) Electron micrograms of the wild-type (top row)
and Walker-A mutant (second row) SMC-ScpAB
complexes. The transition-state mutant com-
plexes were visualized in the absence (third row)
and presence (fourth row) of ATP-Mg2+.
See also Table S1.
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Crystal Structure of ScpAB Complexof HD or HDAB, the HDAB stimulated the SMC ATPase activity
much more potently than did the HD. This stimulation was
reversed when a 20-mer synthetic peptide corresponding to
the ScpA helix H7 region (Ap) was added into the reaction
mixture. It is therefore most likely that the helix H7 present in
HDAB is actively involved in engagement between between
HDAB and one HD of the SMC dimer. A similar effect of the
peptide was observed when the HDAB was replaced with
ScpAB.
We found that addition of ScpA(144–251), which included the
helix H7 region and the CTD, greatly stimulated ATP hydrolysis
catalyzed by the HD (9 ATP/min/mol), and that further addition
of the ScpB dimer has a negative effect on this stimulatory
activity (Figure 6C). Shorter constructs of ScpA (183–251 and
161–251) had little stimulatory activity. These results suggested
that the H7 region of ScpA, when not concealed by ScpB, has
the ability to stimulate ATP hydrolysis via the HD.
Finally, we asked which residues in the helix H7 region might
be important for stimulatory activity. Addition of the wild-type
H7 peptide suppressed the ATPase activity of the HD stimulated
by ScpA(144–251), whereas three mutant peptides (Ap[M156R],
Ap[L157R] and Ap[3LA]) and another overlapping peptide (Ap2)
failed to do so (Figure 6D). Thus, not only are the hydrophobic
residues in which the mutations were introduced involved in
binding to ScpBpo CTD, but they are also responsible for control-
ling the SMC ATPase activity. These findings provide evidence
that the helix H7 region facilitates HD-HD engagement through
its hydrophobic residues.
Subunit Stoichiometry and Asymmetry of the Full-length
SMC-ScpAB Complex
Our crystal structure of the ScpAB core complex revealed that
a single ScpA polypeptide chain is uniquely folded by binding
to ScpB with 1:2 stoichiometry. To understand the subunit stoi-
chiometry in the context of the SMC-ScpAB holocomplex, full-
length SMC, ScpA, and ScpB were coexpressed and purified
to homogeneity. The stoichiometry was found to be 2:1:2 as
judged by gel filtration and SDS-PAGE (Figure 7A). Introduction
of point mutations into the SMC subunit (Walker-A [WA; K37I]
or transition-state [TR]) had little effect on the subunit stoichiom-
etry. Electron microscopic observations revealed that the wild-Structure 21type complex (SMCWT-ScpAB) and the Walker-A mutant
complex (SMCWA-ScpAB) predominantly displayed asymmetric
V-shaped molecules, in which an extra globular part was
attached to one end of the SMC dimer (Figure 7B, first and
second rows). It is most likely that the extra part corresponds
to the ScpAB complex bound to the SMC head domain. Remark-
ably, when the transition-statemutant complex (SMCTR-ScpAB),
but not SMCWT-ScpAB or SMCWA-ScpAB, was mixed with Mg-
ATP, the majority of the molecules displayed a ring-like shape,
most likely due to ATP-mediated engagement of the two SMC
head domains (Figure 7B, compare the third and fourth rows).
The transition-state SMC dimer (SMCTR) also produced similar,
ring-shaped molecules in the presence of Mg-ATP, albeit with
much lower efficiency compared to SMCTR-ScpAB. These
results strongly indicate that although different stoichiometries
of the full-length and subcomplexes have been proposed in
the literature (Fuentes-Perez et al., 2012; Hirano and Hirano,
2004; Mascarenhas et al., 2005), the ratios determined by the
current study are the most likely to be correct. On the other
hand, the E. coliMukF dimerizes through its N-terminal domains
to form a symmetrical structure (along with two MukE dimers) in
which the MukF C-terminal domains are available for MukB
binding. Coexpression of these three molecules generates
heterogeneous species of alternating complexes with the
MukB dimer and the MukEF subcomplex (Matoba et al., 2005).
On the other hand, a recent fluorescent analysis revealed that
a dimer of dimeric MukBEF represents the minimal functional
unit in vivo (Badrinarayanan et al., 2012). Thus, the molecular
features ofMukBEF appear to be intrinsically different from those
of the SMC-ScpAB complex.
Functional Link between ScpAB’s Dynamic Motion and
SMC ATPase Activation
Our current results allow us to describe the relation between
dynamic conformational changes of ScpAB and regulation of
the SMC ATPase activity (Figure 8). The ScpAB subcomplex
binds to the SMC head domain via ScpA’s C-terminal domain.
Anchoring of the ScpBan CTD to ScpA helix H5 induces proper
folding from a free form of ScpA that is inactive in terms of stim-
ulating SMC ATPase. The subsequent binding of the ScpBpo
CTD and winding motion of the subcomplex physically conceals, 581–594, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 591
Figure 8. Model for SMC ATPase Activation Coupled with Dynamic
Motion of ScpAB
ScpA binds to a head domain of SMC through its C-terminal domain. In the
closed form of ScpAB, the ScpB dimer conceals the ScpA helix H7 region.
When the SMC head domain engages the other head domain in the presence
of ATP, ScpAB may convert to the open form in which the ScpBpo CTD is
displaced from the helix H7 region. This open formmay increase the hydrolysis
rate by reposing on the surface of the other SMC head domain.
See also Figure S4.
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proper conversion of ScpA to the latent form that is ready to be
activated upon release of the H7 region from weak binding of
ScpBpo CTD. The observations that ScpAB binds to only one
head domain of an SMC dimer (Figures 7A and 7B) strongly
suggest that the exposed H7 region would be accommodated
by another SMC head domain free of ScpAB. It is reasonable
to speculate, however, that this interaction itself is not constitu-
tive and is largely dependent on ATP-mediated engagement of
the SMC head domains. Conversely, the availability of the H7
region helps promote or stabilize head-head engagement,
thereby stimulating ATP hydrolysis by SMC. Our data are also
consistent with the idea that ATP-mediated engagement would
facilitate conversion of the ScpAB subcomplex from the closed
form to the open form. We suggest that the hydrolysis energy
produced upon the engagement is employed to locally unwind
the closed form by steric clash between ScpAB and the other
SMC head domain.
Recent structural and biochemical data have shown that part
of the middle linker region of MukF makes a contact with the
other side of engaged MukB HDs and thereby induces dissocia-
tion of another MukF from there (Woo et al., 2009). Because this
linker region of MukF stimulates ATP hydrolysis via MukB, we
speculate that it could play a role equivalent to that of the helix
H7 region of ScpA reported in the current study. Although the
MukF linker region is disordered in the published structures of
MukFE (Gloyd et al., 2011; Woo et al., 2009), we suggest that
MukEF could also be converted into a latent form in a way similar
to that observed for ScpAB. Our reevaluation of the MukEF
structure also implies that the last helix of MukE changes its
conformation upon binding to MukF (Figures S4C and S4D)
and thereby suppresses the action of the MukF linker region.
Thus, despite the differences in the subunit architecture and
biochemical properties reported in the literature, it is possible
that these particular aspects of ATPase regulation might be
shared by the SMC-ScpAB and MukBEF complexes.
In the eukaryotic condensin I complex, the regulatory subcom-
plex is composed of three large subunits and plays a role in acti-
vating SMC ATPase (Kimura and Hirano, 2000). Among these592 Structure 21, 581–594, April 2, 2013 ª2013 Elsevier Ltd All rightssubunits, the CAP-H subunit, a member of the kleisin family,
has a central flexible linker flanked by its N- and C-terminal
domains. Interestingly, two HEAT repeat-containing subunits
(CAP-D2 and CAP-G) have been shown to bind to distinct
regions of the central linker of CAP-H (Onn et al., 2007), indi-
cating that H(kleisin)-D2-G has a similar configuration to that of
ScpA(kleisin)-ScpB2. It is therefore tempting to speculate that
the conformational changes of a kleisin subunit revealed in the
current study (i.e., concealment and dynamic release of an acti-
vating element from the other regulatory subunits with two
different affinity sites) could in fact be conserved in the eukary-
otic condensin complexes and participate in controlling the
SMC ATPase activity. Future studies should critically address
the similarities and differences between the bacterial and
eukaryotic complexes to draw an integrated picture of how the
SMC protein complexes might work at a mechanistic level.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection
Crystals of the ScpAB core complex were obtained by sitting-drop vapor diffu-
sion against a reservoir solution containing a mixture of 0.49 M NaH2PO4/
0.91 M K2HPO4 at a narrow pH range of 6.8–7.5 at 20
C. The crystals grew
to a typical size of 0.2 3 0.1 3 0.3 mm in the space group P21, with two olig-
omeric complexes per asymmetric unit and diffracted to at least 2.6 A˚ resolu-
tion. Derivative crystals for phase determination were prepared by soaking
10 mM CH3HgCl dissolved in the mother liquor for 1 hr. Crystals of the ScpB
NTD dimer complex were produced by hanging-drop vapor diffusion against
a reservoir solution containing 100 mM Na malonate-HCl (pH 4.0), 3.0–3.3 M
Na formate at 20C. Orthogonal crystals grew to a typical size of 0.3 3
0.23 0.3 mm in the space groupC2, and diffracted to at least 2.4 A˚ resolution.
Cryoprotection for crystals of both types was achieved by transferring step-
wise to the reservoir solution with glycerol to a final concentration of 25%
(v/v). All diffraction data were collected at the BL26B2 beamline at SPring-8.
Structure Determination and Refinement
All diffraction data were indexed and integrated with the HKL2000 program
and processed further using the CCP4 (Winn et al., 2011) and Phenix program
package (Adams et al., 2010). From derivative data of the ScpAB core
complex, a total of 12 Hg sites were identified using SHLEX (Sheldrick,
2008), and experimental phases were solved using single anomalous disper-
sion data measured at the L3 edge of Hg with scattering parameters (f00 =
9.3, Df = 13.1). High solvent content (80%) of the complex crystal allowed
excellent improvement of the electron density map using RESOLVE (Terwil-
liger, 2003). For the ScpB NTD dimer complex, coordinates from the ScpAB
core complex were used as the search model for molecular replacement
with Phaser (Adams et al., 2010), yielding solutions with a good correlation
coefficient. After an initial run of AutoBuild (Adams et al., 2010), structural
models were built with Coot (Emsley et al., 2010) refined with the CNS
(Brunger, 2007) and Phenix program package. Details of the refined models
exhibit low R factors and good stereochemistry. Drawings of the molecular
structures were prepared using Pymol.
Isothermal Titration Calorimetry
Titration experiments were performed at 25C using iTC200 (GE Healthcare).
Solutions containing individual domains were dialyzed against and degassed
in a buffer containing 50 mM Tris-HCl (pH 7.5) and 100 mM NaCl. The cell was
filled with 200 ml of a protein sample and syringe titration was performed by
a volume of 0.4 ml for the first-time injection and 1.3 ml for the subsequent 29
injections at an interval of 120 s. Initial concentrations of the samples in the
reaction cell and syringe are listed in the legend of Figure 2. Integrated heat
data were analyzed using the Origin program according to the manufacturer’s
instructions. Integrated head data were analyzed using the Origin program
according to the manufacturer’s instructions, and the parameters DH (reaction
enthalpy change in cal mol1), Kb (binding constant in M
1), and n (boundreserved
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Crystal Structure of ScpAB Complexprotein in the cell per protein in the syringe) were estimated. The apparent
dissociation constant was calculated as 1/Kb.
Strains and Plasmids for Molecular Genetics
Routine selection andmaintenance ofB. subtilis strains was performed in Luria
Bertani medium at 37C supplemented, as required, with 5 mg/ml chloram-
phenicol, 0.5 mg/ml erythromycin, and/or 7 mg/ml neomycin. When necessary,
various concentrations of IPTG and xylose were added. Transformation of
competent B. subtilis cells was performed according to a standard two-step
starvation protocol using succinate minimal medium. Strains used in this study
are listed in Table S2. Strain BCKA3 was established by transforming the wild-
type 168 strain with the plasmid pncAB through single-crossover recombina-
tion, resulting in the placement of the full-length scpAB genes downstream of
the IPTG-inducible spac promoter (Pspac). Similarly, BCKA4 was established
with the plasmid pcnB so that only the scpB gene came under the control of the
Pspac promoter. DNA fragments encoding various domains of BsScpA and/or
BsScpB were subcloned into the plasmid pX. After linearization, the plasmids
were used to transform BCKA3 or BCKA4 through double-crossover recombi-
nation on amyE sequences, so that the domains of BsScpA and/or BsScpB
were expressed under the control of the xylose-inducible xyl promoter (Pxyl).
Oxidative Disulfide Crosslinking
Oxidation was carried out using 30 mM Cu(II) phenanthroline complex fleshly
prepared by 1:1 mixing with 180 mM phenanthroline in ethanol and 60 mM
CuSO4 in water. The stock was diluted to 1:10 with water immediately before
use. ScpAB (2–3 mM) dissolved in the GF buffer containing 5% (v/v) glycerol
was oxidized by adding 1/10 volume of the copper complex on ice, and the
reaction was terminated after 5 min by adding 15 mM EDTA. The mixture
was passed through a Superdex 200 10/300 GL column (GE Healthcare) to
replace its buffer with the original GF buffer. Reduction of disulfide bonds
was performed by treating the mixture with 5 mM DTT at 4C for 12 hr.
Untreated, oxidized, and reduced samples were mixed 1:1 with SDS sample
buffer containing 25 mM N-ethylmaleimide and no reducing agent, incubated
on ice for 5 min and boiled for 5 min. The products were separated by SDS-
PAGE and were stained with Coomassie Brilliant Blue.
ATPase Assay
ATPase activities of the full-length of SMC protein and its head domain were
measured using EnzChek Phosphate Assay Kit (Molecular Probes) by quanti-
fying 2-amino-6-mercapto-7-methylpurine riboside (MESG), one of the
secondary products of conversion, catalyzed by nucleoside phosphorylase,
from MESG and released inorganic phosphate. The reaction was started at
37C by adding ATP at a final concentration of 0.5 mM into a 200 ml reaction
mixture containing 48 mM Tris-HCl (pH 7.5), 110 mM NaCl, 5 mM MgCl2,
0.2 mM dithiothreitol, and 2% glycerol. Absorbance of the secondary reaction
product was monitored at 360 nm on a microplate reader, SH-9000 (Corona).
Gel Filtration
The dimerized head domain was monitored by gel filtration chromatography
(Superdex 200 10/300 GL) in a running buffer containing 20 mM HEPES-HCl
(pH 7.5), 150 mM NaCl, 1 mMMgCl2, and 0.1 mM ATP at 4
C. Loaded protein
samples were mixed in the running buffer with extra additives of 10 mMMgCl2
and 1 mM ATP at room temperature. Wild-type and mutant complexes
composed of full-length SMC and ScpAB were subjected to a gel filtration
column (Superose 6 10/300 GL) in a running buffer containing 20 mM Tris-
HCl (pH 7.5) and 300 mM NaCl at 4C. Subunit stoichiometry of the purified
complexes was estimated by comparison with individually purified standard
samples (SMC and ScpAB complex) on SDS-PAGE using LAS3000 (Fuji film).
Electron Microscopy
Purified SMC-ScpAB complexes were diluted with 50% (v/v) glycerol contain-
ing 0.3 M ammonium acetate to a final concentration of 0.03 mg/ml. When
necessary, the buffer was supplemented with 3 mM MgCl2 and ATP. The
samples were sprayed onto a freshly cleaved mica surface and dried under
vacuum. The complex molecules were rotary-shadowed with platinum at an
angle of 6 and supported with carbon at an angle of 90 (HITACHI HUS-
5GB). The shadowed platinum films were removed from the mica on the water
surface and mounted on copper grids. The replicas were examined at 40,000-Structure 21fold magnification using an electron microscope (JEOL JEM-1230) operating
at 80 kV.
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